{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:38:22Z","timestamp":1791041902067,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00431-022-04497-6","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T11:23:33Z","timestamp":1652700213000},"page":"2919-2926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Epilepsy in a cohort of children with Noonan syndrome and related disorders"],"prefix":"10.1007","volume":"181","author":[{"given":"Chiara","family":"Davico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6358-5937","authenticated-orcid":false,"given":"Rossella","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Borgogno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippa","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Torta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Amianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Vittorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetto","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Ferrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"4497_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.beem.2010.09.002","volume":"25","author":"M Tartaglia","year":"2011","unstructured":"Tartaglia M, Gelb BD, Zenker M (2011) Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab 25:161\u2013179. https:\/\/doi.org\/10.1016\/j.beem.2010.09.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4497_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","volume":"381","author":"AE Roberts","year":"2013","unstructured":"Roberts AE, Allanson JE, Tartaglia M, Gelb BD (2013) Noonan syndrome. Lancet 381:333\u2013342. https:\/\/doi.org\/10.1016\/S0140-6736(12)61023-X","journal-title":"Lancet"},{"key":"4497_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000276766","volume":"1","author":"M Tartaglia","year":"2010","unstructured":"Tartaglia M, Zampino G, Gelb BD (2010) Noonan syndrome: clinical aspects and molecular pathogenesis. Mol Syndromol 1:2\u201326. https:\/\/doi.org\/10.1159\/000276766","journal-title":"Mol Syndromol"},{"key":"4497_CR4","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1542\/peds.2009-3207","volume":"126","author":"AA Romano","year":"2010","unstructured":"Romano AA, Allanson JE, Dahlgren J et al (2010) Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics 126:746\u2013759. https:\/\/doi.org\/10.1542\/peds.2009-3207","journal-title":"Pediatrics"},{"key":"4497_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.genom.6.080604.162305","volume":"6","author":"M Tartaglia","year":"2005","unstructured":"Tartaglia M, Gelb BD (2005) Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet 6:45\u201368. https:\/\/doi.org\/10.1146\/annurev.genom.6.080604.162305","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"4497_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1136\/adc.2006.104547","volume":"92","author":"AC Shaw","year":"2007","unstructured":"Shaw AC, Kalidas K, Crosby AH et al (2007) The natural history of Noonan syndrome: a long-term follow-up study. Arch Dis Child 92:128\u2013132. https:\/\/doi.org\/10.1136\/adc.2006.104547","journal-title":"Arch Dis Child"},{"key":"4497_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ng772","volume":"29","author":"M Tartaglia","year":"2001","unstructured":"Tartaglia M, Mehler EL, Goldberg R et al (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465\u2013468. https:\/\/doi.org\/10.1038\/ng772","journal-title":"Nat Genet"},{"key":"4497_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","volume":"14","author":"KA Rauen","year":"2013","unstructured":"Rauen KA (2013) The RASopathies. Annu Rev Genomics Hum Genet 14:355\u2013369. https:\/\/doi.org\/10.1146\/annurev-genom-091212-153523","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"4497_CR9","doi-asserted-by":"publisher","unstructured":"Kim YE, Baek ST (2019) Neurodevelopmental aspects of RASopathies. Mol Cells 42:441\u2013447. https:\/\/doi.org\/10.14348\/molcells.2019.0037","DOI":"10.14348\/molcells.2019.0037"},{"key":"4497_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13041-019-0517-5","volume":"12","author":"M Kang","year":"2019","unstructured":"Kang M, Lee Y-S (2019) The impact of RASopathy-associated mutations on CNS development in mice and humans. Mol Brain 12:96. https:\/\/doi.org\/10.1186\/s13041-019-0517-5","journal-title":"Mol Brain"},{"key":"4497_CR11","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/DBP.0000000000000991","volume":"43","author":"C Davico","year":"2022","unstructured":"Davico C, Borgogno M, Campagna F et al (2022) Psychopathology and adaptive functioning in children, adolescents, and young adults with Noonan syndrome. J Dev Behav Pediatr 43:e87\u2013e93. https:\/\/doi.org\/10.1097\/DBP.0000000000000991","journal-title":"J Dev Behav Pediatr"},{"key":"4497_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/adc.67.2.178","volume":"67","author":"M Sharland","year":"1992","unstructured":"Sharland M, Burch M, McKenna WM, Paton MA (1992) A clinical study of Noonan syndrome. Arch Dis Child 67:178\u2013183. https:\/\/doi.org\/10.1136\/adc.67.2.178","journal-title":"Arch Dis Child"},{"key":"4497_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000331266","volume":"1","author":"MC Digilio","year":"2011","unstructured":"Digilio MC, Lepri F, Baban A et al (2011) RASopathies: clinical diagnosis in the first year of life. Mol Syndromol 1:282\u2013289. https:\/\/doi.org\/10.1159\/000331266","journal-title":"Mol Syndromol"},{"key":"4497_CR14","doi-asserted-by":"publisher","DOI":"10.1017\/S1462399408000902","volume":"10","author":"WE Tidyman","year":"2008","unstructured":"Tidyman WE, Rauen KA (2008) Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway. Expert Rev Mol Med 10:e37. https:\/\/doi.org\/10.1017\/S1462399408000902","journal-title":"Expert Rev Mol Med"},{"key":"4497_CR15","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1469-8749.2007.00894.x","volume":"49","author":"G Yoon","year":"2007","unstructured":"Yoon G, Rosenberg J, Blaser S, Rauen KA (2007) Neurological complications of cardio-facio-cutaneous syndrome. Dev Med Child Neurol 49:894\u2013899. https:\/\/doi.org\/10.1111\/j.1469-8749.2007.00894.x","journal-title":"Dev Med Child Neurol"},{"key":"4497_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/jmg.2007.054460","volume":"45","author":"CM Armour","year":"2008","unstructured":"Armour CM, Allanson JE (2008) Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations. J Med Genet 45:249\u2013254. https:\/\/doi.org\/10.1136\/jmg.2007.054460","journal-title":"J Med Genet"},{"key":"4497_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.braindev.2010.03.008","volume":"33","author":"K Aizaki","year":"2011","unstructured":"Aizaki K, Sugai K, Saito Y et al (2011) Cardio-facio-cutaneous syndrome with infantile spasms and delayed myelination. Brain Dev 33:166\u2013169. https:\/\/doi.org\/10.1016\/j.braindev.2010.03.008","journal-title":"Brain Dev"},{"key":"4497_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.seizure.2011.07.013","volume":"21","author":"M Adachi","year":"2012","unstructured":"Adachi M, Abe Y, Aoki Y, Matsubara Y (2012) Epilepsy in RAS\/MAPK syndrome: two cases of cardio-facio-cutaneous syndrome with epileptic encephalopathy and a literature review. Seizure 21:55\u201360. https:\/\/doi.org\/10.1016\/j.seizure.2011.07.013","journal-title":"Seizure"},{"key":"4497_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.braindev.2012.12.007","volume":"36","author":"K Wakusawa","year":"2014","unstructured":"Wakusawa K, Kobayashi S, Abe Y et al (2014) A girl with cardio-facio-cutaneous syndrome complicated with status epilepticus and acute encephalopathy. Brain Dev 36:61\u201363. https:\/\/doi.org\/10.1016\/j.braindev.2012.12.007","journal-title":"Brain Dev"},{"key":"4497_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1824-7288-38-48","volume":"38","author":"D Capalbo","year":"2012","unstructured":"Capalbo D, Scala MG, Melis D et al (2012) Clinical heterogeneity in two patients with Noonan-like syndrome associated with the same SHOC2 mutation. Ital J Pediatr 38:48. https:\/\/doi.org\/10.1186\/1824-7288-38-48","journal-title":"Ital J Pediatr"},{"key":"4497_CR21","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1002\/ajmg.a.36697","volume":"164A","author":"G Baldassarre","year":"2014","unstructured":"Baldassarre G, Mussa A, Banaudi E et al (2014) Phenotypic variability associated with the invariant SHOC2 c.4A>G (p.Ser2Gly) missense mutation. Am J Med Genet A 164A:3120\u20133125. https:\/\/doi.org\/10.1002\/ajmg.a.36697","journal-title":"Am J Med Genet A"},{"key":"4497_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1272\/jnms.83.167","volume":"83","author":"T Hatori","year":"2016","unstructured":"Hatori T, Sugiyama Y, Yamashita S et al (2016) Vigabatrin therapy for infantile spasms in a case of cardiofaciocutaneous syndrome with cardiac hypertrophy developing during adrenocorticotropic hormone treatment. J Nippon Med Sch 83:167\u2013171. https:\/\/doi.org\/10.1272\/jnms.83.167","journal-title":"J Nippon Med Sch"},{"key":"4497_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/jmg.2006.042796","volume":"43","author":"A Roberts","year":"2006","unstructured":"Roberts A, Allanson J, Jadico SK et al (2006) The cardiofaciocutaneous syndrome. J Med Genet 43:833\u2013842. https:\/\/doi.org\/10.1136\/jmg.2006.042796","journal-title":"J Med Genet"},{"key":"4497_CR24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ejmg.2008.06.011","volume":"51","author":"GB Ferrero","year":"2008","unstructured":"Ferrero GB, Baldassarre G, Delmonaco AG et al (2008) Clinical and molecular characterization of 40 patients with Noonan syndrome. Eur J Med Genet 51:566\u2013572. https:\/\/doi.org\/10.1016\/j.ejmg.2008.06.011","journal-title":"Eur J Med Genet"},{"key":"4497_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G et al (2017) ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58:512\u2013521. https:\/\/doi.org\/10.1111\/epi.13709","journal-title":"Epilepsia"},{"key":"4497_CR26","doi-asserted-by":"publisher","unstructured":"Richardson RD, Burns MK (2005) Adaptive behavior assessment system (2nd Edition) by Harrison, P. L., & Oakland, T. (2002). San Antonio, TX: Psychological Corporation. Assess Eff Interv 30:51\u201354. https:\/\/doi.org\/10.1177\/073724770503000407","DOI":"10.1177\/073724770503000407"},{"key":"4497_CR27","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1528-1157.1995.tb01629.x","volume":"36","author":"CC Murphy","year":"1995","unstructured":"Murphy CC, Trevathan E, Yeargin-Allsopp M (1995) Prevalence of epilepsy and epileptic seizures in 10-year-old children: results from the Metropolitan Atlanta Developmental Disabilities Study. Epilepsia 36:866\u2013872. https:\/\/doi.org\/10.1111\/j.1528-1157.1995.tb01629.x","journal-title":"Epilepsia"},{"key":"4497_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1542\/peds.2010-1371","volume":"129","author":"SA Russ","year":"2012","unstructured":"Russ SA, Larson K, Halfon N (2012) A national profile of childhood epilepsy and seizure disorder. Pediatrics 129:256\u2013264. https:\/\/doi.org\/10.1542\/peds.2010-1371","journal-title":"Pediatrics"},{"key":"4497_CR29","first-page":"0324","volume":"2014","author":"LD Mewasingh","year":"2014","unstructured":"Mewasingh LD (2014) Febrile seizures. BMJ. Clin Evid 2014:0324","journal-title":"Clin Evid"},{"key":"4497_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM197611042951901","volume":"295","author":"KB Nelson","year":"1976","unstructured":"Nelson KB, Ellenberg JH (1976) Predictors of epilepsy in children who have experienced febrile seizures. N Engl J Med 295:1029\u20131033. https:\/\/doi.org\/10.1056\/NEJM197611042951901","journal-title":"N Engl J Med"},{"key":"4497_CR31","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1001\/jamapediatrics.2019.3343","volume":"173","author":"JW Dreier","year":"2019","unstructured":"Dreier JW, Li J, Sun Y, Christensen J (2019) Evaluation of long-term risk of epilepsy, psychiatric disorders, and mortality among children with recurrent febrile seizures: a national cohort study in Denmark. JAMA Pediatr 173:1164\u20131170. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.3343","journal-title":"JAMA Pediatr"},{"key":"4497_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/s-0030-1262840","volume":"41","author":"E Demir","year":"2010","unstructured":"Demir E, Mancano G, Pomponi MG et al (2010) Cardio-facio-cutaneous syndrome: phenotypic variability and differential diagnosis in 3 cases with de novo BRAF mutations. Neuropediatrics 41:127\u2013131. https:\/\/doi.org\/10.1055\/s-0030-1262840","journal-title":"Neuropediatrics"},{"key":"4497_CR33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1469-8749.1993.tb11718.x","volume":"35","author":"G Raymond","year":"1993","unstructured":"Raymond G, Holmes LB (1993) Cardio-facio-cutaneous (CFC) syndrome: neurological features in two children. Dev Med Child Neurol 35:727\u2013732. https:\/\/doi.org\/10.1111\/j.1469-8749.1993.tb11718.x","journal-title":"Dev Med Child Neurol"},{"key":"4497_CR34","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1073\/pnas.1016933108","volume":"108","author":"J Urosevic","year":"2011","unstructured":"Urosevic J, Sauzeau V, Soto-Montenegro ML et al (2011) Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome. Proc Natl Acad Sci U S A 108:5015\u20135020. https:\/\/doi.org\/10.1073\/pnas.1016933108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4497_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s10038-020-00852-3","volume":"66","author":"Y Lee","year":"2021","unstructured":"Lee Y, Choi Y, Seo GH et al (2021) Clinical and molecular spectra of BRAF-associated RASopathy. J Hum Genet 66:389\u2013399. https:\/\/doi.org\/10.1038\/s10038-020-00852-3","journal-title":"J Hum Genet"},{"key":"4497_CR36","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/s41591-018-0172-x","volume":"24","author":"HY Koh","year":"2018","unstructured":"Koh HY, Kim SH, Jang J et al (2018) BRAF somatic mutation contributes to intrinsic epileptogenicity in pediatric brain tumors. Nat Med 24:1662\u20131668. https:\/\/doi.org\/10.1038\/s41591-018-0172-x","journal-title":"Nat Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04497-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-022-04497-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04497-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T10:09:08Z","timestamp":1659607748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-022-04497-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["4497"],"URL":"https:\/\/doi.org\/10.1007\/s00431-022-04497-6","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"assertion":[{"value":"31 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed according to the principles of the Declaration of Helsinki. Approval was granted by the institutional ethics committee \u201cComitato Etico Interaziendale A.O.U. Citt\u00e0 della Salute e della Scienza di Torino\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All probands and\/or their parents or legal guardians gave written informed consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"In the last 2\u00a0years, BV served as a paid consultant to Medice, Angelini, and Menarini Pharmaceuticals; FR received sponsorship from PTC Therapeutics, Novartis, Roche, Sarepta, Sanofi-Genzyme, and Biogen; and CD received consultation feed from Roche Pharmaceuticals. The remaining authors have no conflict of interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}